Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 196

1.

DiscoverSL: An R package for Multi-omic data driven prediction of synthetic lethality in cancers.

Das S, Deng X, Camphausen K, Shankavaram U.

Bioinformatics. 2018 Jul 28. doi: 10.1093/bioinformatics/bty673. [Epub ahead of print]

PMID:
30059974
2.

The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo.

Wahba A, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Aug;17(8):1717-1726. doi: 10.1158/1535-7163.MCT-17-1303. Epub 2018 Jun 4.

PMID:
29866745
3.

Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM.

Rowe LS, Butman JA, Mackey M, Shih JH, Cooley-Zgela T, Ning H, Gilbert MR, Smart DK, Camphausen K, Krauze AV.

J Neurooncol. 2018 May 16. doi: 10.1007/s11060-018-2855-z. [Epub ahead of print]

PMID:
29767308
4.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM.

Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Review.

PMID:
29726389
5.

The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts.

Timme CR, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Jun;17(6):1207-1216. doi: 10.1158/1535-7163.MCT-17-1267. Epub 2018 Mar 16.

PMID:
29549168
6.

Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.

Rath BH, Waung I, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 May;17(5):1070-1078. doi: 10.1158/1535-7163.MCT-17-1053. Epub 2018 Feb 26.

PMID:
29483212
7.

Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA.

Wahba A, Ryan MC, Shankavaram UT, Camphausen K, Tofilon PJ.

Oncotarget. 2017 Oct 9;9(1):691-705. doi: 10.18632/oncotarget.21672. eCollection 2018 Jan 2.

8.

Correction to expert consensus on re-irradiation for recurrent glioma.

Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K.

Radiat Oncol. 2018 Jan 18;13(1):8. doi: 10.1186/s13014-018-0955-8.

9.

Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.

Hao S, Song H, Zhang W, Seldomridge A, Jung J, Giles AJ, Hutchinson MK, Cao X, Colwell N, Lita A, Larion M, Maric D, Abu-Asab M, Quezado M, Kramp T, Camphausen K, Zhuang Z, Gilbert MR, Park DM.

Neuro Oncol. 2018 May 18;20(6):799-809. doi: 10.1093/neuonc/nox241.

PMID:
29294092
10.

LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.

Ho WS, Sizdahkhani S, Hao S, Song H, Seldomridge A, Tandle A, Maric D, Kramp T, Lu R, Heiss JD, Camphausen K, Gilbert MR, Zhuang Z, Park DM.

Cancer Lett. 2018 Feb 28;415:217-226. doi: 10.1016/j.canlet.2017.11.035. Epub 2017 Dec 2.

PMID:
29199006
11.

Expert consensus on re-irradiation for recurrent glioma.

Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K.

Radiat Oncol. 2017 Dec 1;12(1):194. doi: 10.1186/s13014-017-0928-3. Erratum in: Radiat Oncol. 2018 Jan 18;13(1):8.

12.

Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.

Krauze AV, Peters C, Cheng J, Ning H, Mackey M, Rowe L, Cooley-Zgela T, Smart DD, Camphausen K.

Radiat Oncol. 2017 Nov 29;12(1):191. doi: 10.1186/s13014-017-0930-9.

13.

Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation.

Yasui H, Kawai T, Matsumoto S, Saito K, Devasahayam N, Mitchell JB, Camphausen K, Inanami O, Krishna MC.

Free Radic Res. 2017 Oct;51(9-10):861-871. doi: 10.1080/10715762.2017.1388506.

PMID:
29076398
14.

Brain tumor segmentation using holistically nested neural networks in MRI images.

Zhuge Y, Krauze AV, Ning H, Cheng JY, Arora BC, Camphausen K, Miller RW.

Med Phys. 2017 Oct;44(10):5234-5243. doi: 10.1002/mp.12481. Epub 2017 Aug 20.

15.

Computational analysis of the mesenchymal signature landscape in gliomas.

Celiku O, Tandle A, Chung JY, Hewitt SM, Camphausen K, Shankavaram U.

BMC Med Genomics. 2017 Mar 9;10(1):13. doi: 10.1186/s12920-017-0252-7.

17.

Multivariate Analysis of Radiation Responsive Proteins to Predict Radiation Exposure in Total-Body Irradiation and Partial-Body Irradiation Models.

Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K.

Radiat Res. 2017 Feb;187(2):251-258. doi: 10.1667/RR14558.1. Epub 2017 Jan 24.

18.

Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint Revisited.

Tandle A, Camphausen K.

J Cancer Clin Trials. 2016 May;1(2). pii: 111. Epub 2016 May 2. No abstract available.

19.

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.

Maachani UB, Shankavaram U, Kramp T, Tofilon PJ, Camphausen K, Tandle AT.

Oncotarget. 2016 Nov 22;7(47):77365-77377. doi: 10.18632/oncotarget.12670.

20.

State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure.

Sproull M, Camphausen K.

Radiat Res. 2016 Nov;186(5):423-435. Epub 2016 Oct 6. Review.

Supplemental Content

Loading ...
Support Center